Skip to main content

Genetic variants in guanylyl cyclase and phoshodiesterase affecting coronary disease risk

Impaired guanylyl cyclase activity (sGC) may be considered as a cardio-vascular risk factor. In order to study such association with genetic tools, we investigated the role of the GUCY 1A3 locus in genomewide association studies as well as families with premature coronary artery disease. We discovered genomewide significance for association between rs7692387 with coronary artery disease / myocardial infarction in the CARDIoGRAMplusC4D study. Moreover, we discovered mutations in the GUCY 1A3 gene in families with premature coronary disease. Functional studies revealed that impaired guanylyl cyclase activity was the most likely functional link between the genetic variations and the increased risk of coronary disease.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Heribert Schunkert.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Schunkert, H. Genetic variants in guanylyl cyclase and phoshodiesterase affecting coronary disease risk. BMC Pharmacol Toxicol 14, O6 (2013). https://doi.org/10.1186/2050-6511-14-S1-O6

Download citation

Keywords

  • Coronary Artery Disease
  • Genetic Variant
  • Myocardial Infarction
  • Association Study
  • Disease Risk